ZIVO BIOSCIENCE INC (ZIVO) Stock Overview
USA - NASDAQ:ZIVO - US98978N3098 - Common Stock
ZIVO Key Statistics, Chart & Performance
The current stock price of ZIVO is 1.1 USD. In the past month the price decreased by -67.26%. In the past year, price decreased by -93.39%.
ZIVO Latest News, Press Relases and Analysis
ZIVO Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| UL | UNILEVER PLC-SPONSORED ADR | 23.94 | 153.76B | ||
| EL | ESTEE LAUDER COMPANIES-CL A | 66.97 | 36.20B | ||
| KVUE | KENVUE INC | 14.09 | 28.94B | ||
| ELF | ELF BEAUTY INC | 39.68 | 7.16B | ||
| BRBR | BELLRING BRANDS INC | 14.7 | 4.02B | ||
| COTY | COTY INC-CL A | 18.64 | 3.58B | ||
| IPAR | INTERPARFUMS INC | 18.75 | 3.08B | ||
| ODD | ODDITY TECH LTD-CL A | 22.09 | 2.70B | ||
| EPC | EDGEWELL PERSONAL CARE CO | 7.57 | 907.83M | ||
| HLF | HERBALIFE LTD | 3.89 | 845.50M | ||
| YSG | YATSEN HOLDING LTD-ADR | N/A | 735.24M | ||
| OLPX | OLAPLEX HOLDINGS INC | 13.63 | 727.12M |
Related stock screener links
About ZIVO
Company Profile
Zivo Bioscience Inc is a US-based company operating in Personal Care Products industry. The company is headquartered in Bloomfield Hills, Michigan and currently employs 8 full-time employees. The company went IPO on 2000-10-06. Zivo Bioscience, Inc. is a research and development company. The firm operates in both the biotech and agtech sectors, with an intellectual property portfolio comprised of algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques and patented or patent-pending inventions for applications in human and animal health. Its products include Poultry Gut Health, Bovine Mastitis, Canine Joint Health, Human Immune Modification, Algal biomass for human consumption and Biomass for supporting skin health / anti-aging. The firm is also engaged in licensing and selling natural bioactive ingredients derived from their algae cultures to animal, human and dietary supplement and medical food manufacturers. Its product candidates are at different stages of development for different applications.
Company Info
ZIVO BIOSCIENCE INC
21 E. Long Lake Road, Suite 100
Bloomfield Hills MICHIGAN US
CEO: Andrew Dahl
Employees: 8
Phone: 12484529866.0
ZIVO BIOSCIENCE INC / ZIVO FAQ
Can you describe the business of ZIVO BIOSCIENCE INC?
Zivo Bioscience Inc is a US-based company operating in Personal Care Products industry. The company is headquartered in Bloomfield Hills, Michigan and currently employs 8 full-time employees. The company went IPO on 2000-10-06. Zivo Bioscience, Inc. is a research and development company. The firm operates in both the biotech and agtech sectors, with an intellectual property portfolio comprised of algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques and patented or patent-pending inventions for applications in human and animal health. Its products include Poultry Gut Health, Bovine Mastitis, Canine Joint Health, Human Immune Modification, Algal biomass for human consumption and Biomass for supporting skin health / anti-aging. The firm is also engaged in licensing and selling natural bioactive ingredients derived from their algae cultures to animal, human and dietary supplement and medical food manufacturers. Its product candidates are at different stages of development for different applications.
Can you provide the latest stock price for ZIVO BIOSCIENCE INC?
The current stock price of ZIVO is 1.1 USD. The price decreased by -4.35% in the last trading session.
Does ZIVO BIOSCIENCE INC pay dividends?
ZIVO does not pay a dividend.
How is the ChartMill rating for ZIVO BIOSCIENCE INC?
ZIVO has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
Can you provide the PE ratio for ZIVO stock?
ZIVO BIOSCIENCE INC (ZIVO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-5.58).
What is the outstanding short interest for ZIVO BIOSCIENCE INC?
The outstanding short interest for ZIVO BIOSCIENCE INC (ZIVO) is 3.7% of its float.
ZIVO Technical Analysis
ZIVO Financial Highlights
Over the last trailing twelve months ZIVO reported a non-GAAP Earnings per Share(EPS) of -5.58. The EPS increased by 1.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -404.76% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ZIVO Forecast & Estimates
7 analysts have analysed ZIVO and the average price target is 36.72 USD. This implies a price increase of 3238.18% is expected in the next year compared to the current price of 1.1.